Figure 5
Lipistase prevents hepatic steatosis. (A) Liver paraffin-embedded sections, stained with haematoxylin and eosin (upper panels) from animals after 10-month lipistase treatment vs. controls (bars = 100 μm); Oil-red O staining of equivalent sections (lower panels) (bars = 50 µm). (B) Levels of cholesterol esters and triglycerides in the liver of the same animals. (C) mRNA expression levels of lipogenic markers and (D) of fatty acid transport and catabolism markers (*P<0.05; **P<0.01).

Lipistase prevents hepatic steatosis. (A) Liver paraffin-embedded sections, stained with haematoxylin and eosin (upper panels) from animals after 10-month lipistase treatment vs. controls (bars = 100 μm); Oil-red O staining of equivalent sections (lower panels) (bars = 50 µm). (B) Levels of cholesterol esters and triglycerides in the liver of the same animals. (C) mRNA expression levels of lipogenic markers and (D) of fatty acid transport and catabolism markers (*P<0.05; **P<0.01).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close